MedTrace Logo

Discovery of New Circulating Biomarkers of Coronary Atherosclerosis

NCT00430820 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 124

Last updated 2010-12-03

No results posted yet for this study

Summary

The study hypothesis is that differential proteomic techniques can be used to discover new circulating biomarkers of coronary atherosclerosis in the blood of patients suffering from coronary artery disease (either stable or unstable) who will be compared to a group of patients without coronary artery disease

Conditions

Interventions

PROCEDURE

per intervention

per intervention

Sponsors & Collaborators

  • Fédération Française de Cardiologie

    collaborator OTHER

  • Société Française de Cardiologie

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Laurent FELDMAN, MD,PhD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2009-07-31
Completion
2009-11-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00430820 on ClinicalTrials.gov